Induction of Epstein-Barr Virus Kinases To Sensitize Tumor Cells to Nucleoside Analogues

The presence of Epstein-Barr virus (EBV) in the tumor cells of some EBV-associated malignancies may facilitate selective killing of these tumor cells. We show that treatment of an EBV(+) Burkitt's lymphoma cell line with 5-azacytidine led to a dose-dependent induction of EBV lytic antigen expre...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Moore, Stacy M., Cannon, Jennifer S., Tanhehco, Yvette C., Hamzeh, Fayez M., Ambinder, Richard F.
Format: Article
Langue:en
Publié: American Society for Microbiology 2001
Sujets:
Antiviral Agents
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC90604/
https://ncbi.nlm.nih.gov/pubmed/11408227
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.45.7.2082-2091.2001
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://ncbi.nlm.nih.gov/pmc/articles/PMC90604/
https://ncbi.nlm.nih.gov/pubmed/11408227
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.45.7.2082-2091.2001

Documents similaires